Standard Biotools (LAB) Depreciation and Depletion (2023 - 2026)

Standard Biotools (LAB) has 4 years of Depreciation and Depletion data on file, last reported at $1.4 million in Q1 2026.

• Quarterly Depreciation and Depletion fell 33.33% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.2 million (up 26.53% YoY) and the FY2025 annual result came in at $6.9 million, up 81.58% from the prior year.
• Depreciation and Depletion rose to $1.4 million in Q1 2026 per LAB's latest filing, from $1.3 million in the prior quarter.
• Across five years, Depreciation and Depletion topped out at $3.0 million in Q1 2024 and bottomed at $700000.0 in Q1 2023.
• The 4-year median for Depreciation and Depletion is $1.3 million (2025), against an average of $1.5 million.
• The widest annual swing landed in 2024, when Depreciation and Depletion soared 328.57%; it then slumped 33.33% in 2026.
• Tracing LAB's Depreciation and Depletion over 4 years: stood at $700000.0 in 2023, then advanced by 14.29% to $800000.0 in 2024, then jumped by 62.5% to $1.3 million in 2025, then climbed by 7.69% to $1.4 million in 2026.
• Per Business Quant, the three latest LAB Depreciation and Depletion figures stand at $1.4 million (Q1 2026), $1.3 million (Q4 2025), and $1.5 million (Q3 2025).

Peer Comparison